DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, has entered into a new contract outlining plans to provide is cardiometabolic solution to an employer. The contract will begin in January 2024. The new contract is the latest is a growing number of similar agreements, indicating that demand for Dario’s integrated solutions continues to grow as employers facing the surge in GLP-1 medication usage search for ways to change health behaviors. According to the announcement, the employer is a national financial and business services company that chose Dario as a solution to help improve the cardiometabolic health of its employees with an integrated solution for diabetes, prediabetes, weight management and hypertension; the proprietary DRIO program also offers tailored support for employees taking GLP-1 medications. “Dario is seeing increased interest in our proven ability to help people achieve better cardiometabolic health through sustained behavior change, a requirement for people using medications such as GLP-1s,” said Dario president Rick Anderson in the press release. “We are excited to support our new client’s business goals with effective and easy-to-use solutions which we believe employees will love.”
To view the full press release, visit https://ibn.fm/SeTKs
About DarioHealth Corp.
DarioHealth Corp. is a leading digital health company revolutionizing how people with chronic conditions manage their health through a user-centric, multichronic condition digital therapeutics platform. Dario’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health. The company’s user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention and results, and making the right thing to do the easy thing to do. Dario provides its highly user-rated solutions globally to health plans and other payors, self-insured employers and providers of care as well as directly to consumers. For more information about the company, please visit www.DarioHealth.com.
NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO
About InvestorWire
InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer
InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com
InvestorWire is powered by IBN
